2^nd Global Experts Meeting on Infectious Diseases February 27-28, 2019 | Radisson Hotel Narita | Tokyo, Japan

Biography:

Dr. Goutam Kumar Acherjya is working as a junior consultant of Medicine in the Upazila Health Complex, Bagherpara, Jashore, Bangladesh. He has obtained his MBBS degree from Sher-E-Bangla Medical College & Hospital under University of Dhaka, Bangladesh in 2003 and completed Fellowship (FCPS) in internal medicine in 2011 from Bangladesh College of Physician and Surgeon (BCPS), Bangladesh. He has completed Fellowship training under Emeritus Prof. AV Srinivashan in AVS Clinic and Prof. MR Sivakumar in GLB Hospital and Acute Stroke Centre in Chennai, Tamil Nadu, India. He has achieved his Life Membership from Bangladesh Society of Medicine and Bangladesh Medical Association. He has gained his membership from American College of Physician in 2016. He has experience to organize a number of CME, Symposium and Scientific Seminars in the regional, national and international levels. He has delivered several presentations in the prestigious national and international conferences. Recently he has won the Bangladesh Society of Medicine Research Grant Award 2018.  One of his abstract has been selected among the top fifty abstracts in the ACP early carrier abstract competition in 2018. He has delivered both oral and poster presentations in the 34^th World Congress of Internal Medicine, Cape Town, South Africa in 2018. He has 11 national and international publications and several interesting case reports. Some of his articles are on the way to publish in some eminent national and international journals. He has experience to consult at different levels of Bangladesh Health Sectors. Now he is practicing to consult his private patients in Modern Hospital & Diagnostic Centre, Jashore, Bangladesh. He used to consult both indoor and outdoor patients in his working place. As a researcher his areas of interest are Diabetes, Effect of Metabolic disorders on Central Nervous System and Gerentology.

Abstract:

Over the couple of decades the antimicrobial resistance is one of most common global public health problems not only in the developed countries but also developing countries. In the daily clinical practice antibiotics are commonly prescribed in case of respiratory tract infections, many of the genitourinary tract infections, acute of chronic gastroenteritis or other gastro intestinal symptoms, traumatized patients to prevent secondary infections. Antibiotics are commonly used to prevent and control the bacterial infection for reducing the mortalities and morbidities but its resistance has become the major public health challenge in the era of 21^st century. After achieving the millennium development goal, antibiotic resistance will be one of the major stakeholders to set the sustainable developmental goals as the scenario is more endangering and life threatening than our current anticipation. A complex mechanism of interaction between genetic, pathogenic properties, environmental and host factors are related to develop antimicrobial resistance. Out of which several factors including inappropriate antibiotics practicing, patient’s illiteracy, unauthorized sale of antibiotics, inadequate supervision by drug monitoring agencies and non-human use of antibiotics such as animal production are modifiable. Many of the pathogens have shown highly resistance to several commonly used antimicrobials reported in various studies which is really alarming for us. So, the judicious strategies should be planned to prevent and combat against the antimicrobial resistance and make the globe livable for our generation next. 

Biography:

Abstract:

Now preventive maintenance of a flu by means of vaccination is conventional and is supported by experts of all world. To check presence of trypsin-like proteinase and its inhibitor in antiflu and other vaccines and in immunobiological blood preparations of domestic and foreign manufacture. In work following commercial preparations have been used:" Interferon leukocytic human"," the Immunoglobulin of human placental, donor 10 %, a gonococcal vaccine a herpetic vaccine (Odessa), vaccines for preventive maintenance of a flu, a season 2002/2003 -"Influvac" which consists of hemagglutinins and a neuraminidase of a virus of a flu, strains: А/Moscow/10/99 (H3N2), А/New Caledonia/20/99 (H/N), B/Hong Kong/330/2001, "Fluarix" which consists of hemagglutinins of Strains (H1N1) A/New Caledonia (H3N2), А/Panama and Ð’/Shandont 17/97 and "Vaxigrip" which consists of three Strains of a flu virus, a vaccine for preventive maintenance of a Hepatitis A - "Avaxim", a blood preparation received from a

Heparin (the antifactor of Ha) - "Fraxiparine", a preparation from A blood of calfs for a hemodialysis - "Solcoseryl". Preparations Were investigated before the termination of a period of validity. Resuits.Work is devoted to study presence of components of a Cell-owner and its inhibitor in vaccines and blood preparations And to define presence trypsin-like proteinase and its inhibitor in Vaccines and blood preparations. It is revealed that anti Influenza vaccines (influvac, vaxigrip, fluarix), herpetic and

Tularemic vaccines contained an inhibitor of trypsin-like Proteinase in considerable quantity. Commercial preparations From a human donor blood (an immunoglobulin, interferon, Fraxiparine and solcoseryl) contained as trypsin-like proteinase, And its inhibitor. The immunoglobulin contained in 4,0 times more Inhibitor, than interferon. Conclusions. Hence, the modern vaccines

Applied to prophylaxis and treatment, are insufficiently clear. Presence of cellular components (enzymes and inhibitors) could Lead to allergization and follow complication which is not very Known.